Playbook replay
Brand positioning statement
Three positioning variations, then a stress test that kills one of them because a rival could sign it unchanged.
Run for Lumira, a demo brand we invented for this page. No customer data. Nothing here runs against a live account.
Every session here was run once and saved, against a demo brand or public data. On your own account Naise works from your brand voice, your campaigns and your connected channels, so it reasons about your data instead of a stand-in.
The differentiator is the only part of the formula that does any work. Everything else is context. If a rival can claim the same differentiator, the statement is a description, not a position.
Three variations, then I will try to break each one by checking whether a competitor could sign the same sentence with only their name swapped in.
A. For people who have quit a routine before, Lumira is the skincare brand that gets cheaper the longer you stay, because we are built around refills rather than bottles.
B. For people who have quit a routine before, Lumira is the skincare brand designed around the second month, because refills make continuing cost less than starting.
C. For people who have quit a routine before, Lumira is the skincare brand that removes the reasons to stop, because the refill arrives before the bottle runs out.
Now the stress test.
| Version | Could a rival sign it? | Why |
|---|---|---|
| A | No | Price falling over time is a structural claim. A bottle-based brand cannot make it without cutting margin. |
| B | No | "Designed around the second month" is unusual enough to be checkable, and their comms are all acquisition. |
| C | Yes | Any subscription brand delivers before you run out. Two of your competitors already do. |
So C is out. It is the nicest sentence of the three, which is the usual trap.
Between A and B: A is a claim about money and is easy to verify, which makes it strong and also means someone will check it. Your refill is 40% of the bottle price, so the claim holds. B is the more interesting position but needs the second-month experience to actually exist before you say it out loud.
Recommendation: A now, B in two quarters if you build the month-two support to back it.
One honest gap. This is positioned entirely against the price and continuity axis. I have not tested it against the trust axis, where the clinical brands are strong and where you have nothing to say yet. If a customer's reason for quitting was "it did not work" rather than "it ran out", none of these three statements speaks to them.
That is worth knowing before this gets pinned to a wall.
Naise created an artifact
Three versions of the classic frame, one eliminated because a competitor could sign it word for word.
Recommended
For people who have quit a routine before, Lumira is the skincare brand that gets cheaper the longer you stay, because we are built around refills rather than bottles.
Stress test
| Version | Rival could sign it? |
|---|---|
| Cheaper over time | No, structural claim |
| Designed for month two | No, but not yet true |
| Refill arrives before you run out | Yes, two rivals already do |
Gap: says nothing on the trust axis, where clinical brands are strongest.
That was a sample. Run it on your own brand.
Naise reads your brand, your channels, and your market, then does this against your real data.
Run this playbook free